404 Olaparib vs placebo as maintenance therapy after platinum based chemotherapy in advanced/metasta...
404 Olaparib vs placebo as maintenance therapy after platinum based chemotherapy in advanced/metastatic endometrial cancer patients: the GINECO randomized phase IIb UTOLA trial
About this item
Full title
Author / Creator
Joly, Florence , Leary, Alexandra , Ray-Coquard, Isabelle , Asselain, Bernard , Rodrigues, Manuel , Gladieff, Laurence , Bazan, Fernando , Abadie-Lacourtoisie, Sophie , Lebreton, Coriolan , Lefevre, Leïla Bengrine , Leroy, Karen , Leman, Raphaël , Fournel, Pierre , Largillier, Rémy , Selle, Frédéric , Frenel, Jean-Sebastien , Fernandez, Yolanda , Foa, Cyril , You, Benoit and Alexandre, Jérôme
Publisher
Kidlington: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
Introduction/BackgroundUTOLA assessed the efficacy of Parp-inhibitor for advanced/M+ EC pts without progression after 1st line platinum CT and to analyse efficacy in some molecular subgroups.MethodologyUTOLA is a 2/1 randomized, double-blind, placebo controlled, phase IIb trial, comparing olaparib maintenance (ola, 300 mg po BID) vs placebo (pl) un...
Alternative Titles
Full title
404 Olaparib vs placebo as maintenance therapy after platinum based chemotherapy in advanced/metastatic endometrial cancer patients: the GINECO randomized phase IIb UTOLA trial
Authors, Artists and Contributors
Author / Creator
Leary, Alexandra
Ray-Coquard, Isabelle
Asselain, Bernard
Rodrigues, Manuel
Gladieff, Laurence
Bazan, Fernando
Abadie-Lacourtoisie, Sophie
Lebreton, Coriolan
Lefevre, Leïla Bengrine
Leroy, Karen
Leman, Raphaël
Fournel, Pierre
Largillier, Rémy
Selle, Frédéric
Frenel, Jean-Sebastien
Fernandez, Yolanda
Foa, Cyril
You, Benoit
Alexandre, Jérôme
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2956066943
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2956066943
Other Identifiers
ISSN
1048-891X
E-ISSN
1525-1438
DOI
10.1136/ijgc-2024-ESGO.332
